Notable Releases from Emerging-Market Companies: Sapeet, DELTA-P (Fisco)

Among notable releases from emerging markets, Sapeet Inc. raised its previous fiscal year's operating profit forecast from ¥120 million to ¥176 million. DELTA-P's 2 presentations on the clinical trial of DFP-10917 were selected for presentation at ASH2026.

Read in fullFrom the source, not the headline

sources corroborateOutlets reporting the same event

companies linkedAcross 0 themes, second pass

The story

Sapeet Inc.’s operating profit forecast for the previous fiscal year was revised upward from the previous ¥120 million to ¥176 million.

DELTA-P’s 2 presentations on the clinical trial of DFP-10917 were reportedly selected for presentation at ASH2026.

At a glance

Stock movementsSapeet Inc. raises its previous fiscal year's operating profit forecast from ¥120 million to ¥176 million

Clinical developments2 clinical trial presentations on DFP-10917 selected for presentation at ASH2026

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

finance.yahoo.co.jpNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.